CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Executive Officer bought 3,610 shares at $2.78 ($10,024)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $2.78 ($13,883)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.99 ($29,890)
- 4 Open-market buy Chief Medical Officer bought 16,000 shares at $3.07 ($49,120)
- 4 Open-market buy Director bought 20,700 shares at $2.82 ($58,376)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.13 ($15,646)
- 4 Returned to the company Chief Development Officer returned 5,000 shares (to the company)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Development Officer sold 5,216 shares at $5.00 ($26,080)
- 4 Open-market sale Chief Engineering Officer sold 28,351 shares at $5.00 ($141,755)
- 4 Open-market sale Chief Development Officer sold 6,953 shares at $4.50 ($31,289)
- 4 Grant or award Chief Engineering Officer acquired 8,022 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 6,040 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 6,876 shares (grant or award)
Page 10 of 21 · 404 filings